Skip to content
Disclosery

EXANE DERIVATIVES: JPM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on JPM, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 12,673 JPM shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 12,673 shares
    Change vs previous 13F -1,706 shares

    0.82% of the 13F portfolio, value $1,426,792.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 14,379 shares
    Change vs previous 13F -6,739 shares

    0.55% of the 13F portfolio, value $1,959,998.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 21,118 shares
    Change vs previous 13F +2,517 shares

    0.81% of the 13F portfolio, value $3,343,868.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 18,601 shares
    Change vs previous 13F +1,516 shares

    0.76% of the 13F portfolio, value $3,044,647.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 17,085 shares
    Change vs previous 13F +190 shares

    0.62% of the 13F portfolio, value $2,659,198.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 16,895 shares
    Change vs previous 13F +1,537 shares

    0.77% of the 13F portfolio, value $2,571,770.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 15,358 shares
    Change vs previous 13F -2,525 shares

    0.59% of the 13F portfolio, value $1,951,419.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 17,883 shares
    Change vs previous 13F not available

    0.56% of the 13F portfolio, value $1,721,525.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).